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Summary
What is already known on this topic?
Race/ethnicity and rural residence are associated with poorer cervical can-
cer outcomes.
What is added by this report?
We examined the association of rurality with cervical cancer stage at dia-
gnosis by race/ethnicity in the US Cancer Statistics dataset for
2010–2014. Black and Hispanic women had higher incidence of regional
and distant stage cancer than white women overall. Rural residents had
higher rates of cervical cancer than urban residents at every stage (local-
ized, regional, distant, and unknown). The association of rural residence
with incidence varied by race/ethnicity.
What are the implications for public health practice?
Findings support the need for continued efforts to provide and promote
cervical cancer screening in rural areas and among minority women.
Abstract
Introduction
Racial  and  socioeconomic  disparities  exist  in  cervical  cancer
screening, incidence, and mortality. The purpose of this study was
to investigate how cervical cancer stage at diagnosis is associated
with rurality and race/ethnicity.
Methods
We analyzed 2010 through 2014 data from the Centers for Dis-
ease Control and Prevention’s National Program of Cancer Regis-
tries and the National Cancer Institute’s Surveillance, Epidemi-
ology, and End Results Program. We compared cervical cancer
frequency and age-adjusted incidence for each stage by county-
level rurality and race/ethnicity.
Results
There were 59,432 incident cases of cervical cancer reported from
2010 through 2014. The most common stage at diagnosis was loc-
alized (urban, 43.3%; rural 41.3%). Rural counties had higher in-
cidence than urban counties for localized (rate ratio [RR] = 1.11;
95% confidence interval [CI], 1.07–1.15), regional (RR = 1.14;
95% CI, 1.10–1.19), and distant (RR = 1.12; 95% CI, 1.05–1.19)
stage cervical cancer. Hispanic and non-Hispanic black women
had higher incidence of regional and distant cervical cancer than
non-Hispanic white women. Non-Hispanic white women in rural
counties  had higher  incidence than those  in  urban counties  at
every stage. However, incidence for non-Hispanic white women
was lower than for non-Hispanic black or Hispanic women.
Conclusion
Rural counties had higher incidence of cervical cancer than urban
counties at every stage. However, the association of rural resid-
ence with incidence varied by race/ethnicity.
Introduction
Disparities in cervical cancer incidence and mortality are pervas-
ive in the United States, despite improvements in outcomes over
time (1). Understanding these disparities and related social de-
terminants of health is critical to improving care (2). Race, so-
cioeconomic status, and region strongly influence cervical cancer
outcomes (3–5). For example, black women have higher incid-
ence and mortality rates and lower survival rates than white wo-
men. Racial/ethnic disparities may reflect differences in cervical
cancer screening rates and outcomes that vary by socioeconomic
status and access to quality care (6–8). Because regular and timely
screening can detect preclinical cervical lesions and early stage
cancer, access to screening services and follow-up of abnormal
tests can affect stage at diagnosis and overall cervical cancer incid-
ence (9).
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Women in rural areas may experience barriers to optimal cervical
cancer prevention, early detection, and treatment. Overall, cer-
vical cancer incidence and mortality rates are higher in rural and
nonmetropolitan areas than in metropolitan areas (10–12). Studies
have demonstrated lower use of screening services in rural areas
(13,14).
The objective of  this  study was to investigate the relationship
between rurality and cervical cancer stage at diagnosis by analyz-
ing data from population-based cancer registries that cover the US
population. We hypothesized that women in rural areas would
have higher incidence of cervical cancer, particularly advanced-
stage cancer, and that the effect of rurality may vary by race/ethni-
city.
Methods
We analyzed cancer incidence data from the Centers for Disease
Control and Prevention’s (CDC’s) National Program of Cancer
Registries and the National Cancer Institute’s (NCI’s) Surveil-
lance, Epidemiology, and End Results Program. These data are
submitted annually to CDC and NCI and combined (15). We used
data for cancers diagnosed between 2010 and 2014, the most re-
cent 5 years of data available. Data from Nevada did not meet
United States  Cancer  Statistics  (USCS) publication criteria  in
2011, and Kansas and Minnesota do not report county-level data
necessary to determine rurality so data from these states were ex-
cluded.  The  remaining  incidence  data  covered  approximately
96.5% of the US population. We included new cases of primary
invasive cervical cancer (International Classification of Diseases
for Oncology, 3rd edition, codes C53.0-C53.9) diagnosed among
women aged 20 years or older (16). Cases diagnosed by death cer-
tificate only or autopsy (1.1%) were excluded.
Stage was classified using Summary Stage 2000 (https://seer.can-
cer.gov/tools/ssm), which characterizes cancers as localized (con-
fined to primary site), regional (spread directly beyond primary
site or to regional lymph nodes), distant (spread to other organs or
remote lymph nodes), or unknown.
Rural–urban continuum codes (RUCC) from the US Department
of Agriculture broadly describe counties as metropolitan or non-
metropolitan (www.ers.usda.gov/data-products/rural-urban-con-
tinuum-codes). RUCC 1 through 3 describe metropolitan counties
with varying population sizes (≥1,000,000; 250,000– <1,000,000;
and <250,000). Nonmetropolitan counties (RUCC 4–9) are fur-
ther  divided  by  urbanization,  population  size  (<2,500;
2,500–19,999; and ≥20,000), and adjacency to a metropolitan area.
Because exploratory analyses indicated homogeneity within met-
ropolitan and nonmetropolitan categories, data were analyzed by 2
major groups: “urban” (RUCC 1–3) and “rural” (RUCC 4–9), sim-
ilar to methods in other studies (10,17–19).
Data were analyzed for 4 mutually exclusive racial/ethnic groups:
1) non-Hispanic white; 2) non-Hispanic black; 3) non-Hispanic
American Indian/Alaska Native, Asian/Pacific Islander, unspe-
cified race, and other race and unknown (non-Hispanic other); and
4) Hispanic. Information about race and Hispanic ethnicity was
collected separately. To reduce ethnic misclassification, the data-
set uses the North American Association of Central Cancer Regis-
tries (NAACCR) Hispanic Identification Algorithm to assign His-
panic ethnicity (www.naaccr.org/wp-content/uploads/2016/11/
NHIA_v2_2_1_09122011.pdf).
We used SEER*Stat version 8.3.4 (National Cancer Institute) to
calculate average annual  incidence for 2010 through 2014 per
100,000 women for each stage, by race/ethnicity and county type.
Rates  were age-adjusted by the direct  method to the 2000 US
standard population, with 95% confidence intervals (CIs) calcu-
lated as modified gamma intervals. This information can be used
to assess whether the point estimate of one group falls within the
confidence interval of the point estimate of another. Rates based
on fewer  than  16  cases  may have  poor  reliability  and  are  not
presented.
Results
From 2010 through 2014, 59,432 incident cases of cervical cancer
were reported (Table 1). Of these, most were diagnosed in urban
counties (84.5% vs 15.5% in rural counties). Most cases were dia-
gnosed among non-Hispanic  (NH) white  women (60.8%) fol-
lowed by Hispanic (16.9%), NH black (15.7%), and NH other
(6.6%) women. Localized cases were most commonly diagnosed
for all groups except NH black women, for which regional stage
predominated.
Rural counties had higher age-adjusted incidence of localized, re-
gional, and distant cervical cancer than urban counties (Table 1).
Compared with NH white women, Hispanic women had higher in-
cidence of cervical cancer for any stage. NH black women also
had higher rates of regional and distant stage cancer, although
rates of localized cancer were comparable to those of NH white
women. NH black, NH other, and Hispanic women were more
likely than white women to have unknown stage of disease.
Differences in incidence between urban and rural counties varied
by race/ethnicity (Table 2). Among Hispanic women, no differ-
ence was observed for localized, regional, or distant stage cancer.
NH black women in rural counties had higher incidence of region-
al cervical cancer than NH black women in urban counties. NH
white  women in  rural  counties  had higher  incidence  than NH
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white women in urban counties for every stage cervical cancer.
This effect was larger for regional than localized stage. For all ra-
cial/ethnic groups, rates of unknown stage cervical cancer were
higher in rural than urban counties.
Discussion
From 2010 through 2014, incidence of cervical cancer was higher
in rural than urban counties, and this effect was similar for local-
ized, regional, and distant stage cancer. However, the effect of rur-
ality varied by race/ethnicity. White women had higher incidence
of cervical cancer in rural counties for any stage. This pattern was
not observed for black and Hispanic women, though these women
had higher incidence of regional and distant cervical cancer than
white women overall. Increases in these rates for black and His-
panic women appeared to be present among both urban and rural
residents. Higher rates of localized disease for Hispanic women
compared  with  white  women overall  may  be  due  to  the  rates
among urban women.
These results support the need for continued efforts to provide and
promote cervical cancer screening in rural areas and among minor-
ity women. Screening can reduce cervical cancer mortality rates,
especially from regional- and distant-stage cancer that have a poor
prognosis (9,20). The National Breast and Cervical Cancer Early
Detection Program has provided cervical cancer screening ser-
vices to low-income, uninsured women for more than 20 years.
However, the program reaches only a small proportion of eligible
women, and many underserved women remain unscreened (21). In
addition to detecting cancers earlier, screening can also reduce cer-
vical  cancer  incidence through the  detection and treatment  of
precancerous lesions. However, women in rural areas, who may
have limited access to health care, are less likely to be up-to-date
with cervical cancer screening (6,22). Non-Hispanic black and
Hispanic women also had higher incidence of regional- and dis-
tant-stage disease than non-Hispanic white women, which is con-
sistent with the higher overall cervical cancer incidence reported
previously (5,8). Efforts to increase screening use among these
women may help reduce these disparities.
No significant difference was found in localized, regional, or dis-
tant stage disease between rural and urban Hispanic women. Nuño
et al suggested that Hispanic women in rural areas may have lower
screening rates than Hispanic women in urban areas in the south-
western United States (23). Although we did not find differences
between rural and urban Hispanic women, for both of these groups
rates for each stage were higher than those for white women, with
the exception of localized disease for which rates were similar
between rural white and Hispanic women. Additional investiga-
tion may help elucidate why rates are higher for rural, black, and
Hispanic women and may help inform efforts to address barriers
for these groups.
We found that  non-Hispanic  black and Hispanic  women were
more likely than white women to have unknown stage of disease,
consistent with other studies of cancer stage (24–26). Unknown
stage was also more likely among rural compared with urban wo-
men, both overall  and within each racial/ethnic group. The in-
creased likelihood of unknown stage disease among rural resid-
ents  is  consistent  with  some  literature  on  cancer  but  not  all
(26,27). Possible contributing factors include lower rates of insur-
ance coverage (24) and less access to comprehensive diagnostic or
treatment services (27). The reasons for higher rates of unstaged
disease among rural and minority women may warrant further in-
vestigation,  because unstaged cancer has been associated with
worse survival than earlier stage cancers (25,28)
Our study has strengths and limitations. We used high-quality re-
gistry data that cover over 96% of the US population. Analyses
based  on  the  population  better  reflect  national  patterns  than
sample-based estimates. The county rurality codes have been used
widely  to  demonstrate  geographic  differences  (10,17–19).
However, the measure of rurality based on county data offers less
granularity than do census-tract data. Collapsing a multilevel vari-
able into 2 categories may mask differences among subgroups
within each category. However, the small numbers in some strata
limited us from increasing the number of classification groups. Fu-
ture efforts to build on these findings with more detailed informa-
tion about rurality is important. We did not correct for hysterec-
tomy, because cancer registries do not collect this information.
Failure to adjust for hysterectomy status can lead to underestim-
ates of cervical cancer incidence, especially among black women
(5,29). Confounding may have occurred if the prevalence of hys-
terectomy differed between rural and urban counties.
Some factors that may have contributed to observed differences,
such as cervical cancer screening history, were not available in our
data set. Differences in incidence or in rates of later stage disease
may reflect differences in screening use across groups. Hispanic
women were less likely than non-Hispanic women to be recently
screened for cervical cancer in 2015 (30). We observed higher cer-
vical cancer incidence, including higher rates of regional or dis-
tant disease, among Hispanic women compared with non-Hispan-
ic white women. We did not have information about availability of
or proximity to screening and diagnostic services (14). Delays in
receipt of timely diagnosis after an abnormal screening test could
contribute to later stage at diagnosis.
In conclusion, higher cervical cancer incidence among women in
rural areas highlights missed opportunities to implement evidence-
based interventions  to  promote  cancer  screening and increase
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screening use in rural communities.  Multicomponent interven-
tions designed to increase community demand for or access to
cancer screening and to increase provider delivery of screening
services can increase cervical cancer screening use (www.thecom-
munityguide.org/). Consideration is needed of barriers, including
those which may be relevant in rural populations (eg, increased
travel distances). Ensuring access to screening and diagnostic ser-
vices for rural women is critical to reduce cervical cancer disparit-
ies.
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Tables
Table 1. Age-Adjusted Cervical Cancer Incidence (N = 59,432)a and Rate Ratios of All Stages, by Race/Ethnicity and Rurality, US Cancer Statistics 2010–2014b
Cancer Stage
Race/Ethnicity Ruralityc
TotalNH White NH Black Hispanic NH Otherd Urban Rural
Total No. (%) 36,144 (60.8) 9,359 (15.7) 10,024 (16.9) 3,905 (6.6) 50,205 (84.5) 9,227 (15.5) 59,432
Localized
No. (%) 16,080 (44.5) 3,384 (36.2) 4,412 (44.0) 1,688 (43.2) 21,757 (43.3) 3,807 (41.3) 25,564 (43.0)
Rate (95% CI) 4.7 (4.6–4.8) 4.8 (4.6–4.9) 5.6 (5.4–5.8) 4.5 (4.3–4.7) 4.7 (4.6–4.7) 5.2 (5.0–5.4)  —
Rate ratio (95% CI) 1 [Ref] 1.01 (0.97–1.05) 1.19 (1.15–1.23) 0.96 (0.91–1.01) 1 [Ref] 1.11 (1.07–1.15)  —
Regional
No. (%) 12,603 (34.9) 3,719 (39.7) 3,697 (36.9) 1,369 (35.1) 17,981 (35.8) 3,407 (36.9) 21,388 (36.0)
Rate (95% CI) 3.2 (3.2–3.3) 5.2 (5.0–5.4) 5.1 (4.9–5.2) 3.8 (3.6–4.0) 3.6 (3.5–3.7) 4.1 (4.0–4.3)  —
Rate ratio (95% CI) 1 [Ref] 1.62 (1.56–1.68) 1.57 (1.51–1.63) 1.17 (1.10–1.24) 1 [Ref] 1.14 (1.10–1.19)  —
Distant
No. (%) 5,496 (15.2) 1,637 (17.5) 1,266 (12.6) 475 (12.2) 7,434 (14.8) 1,440 (15.6) 8,874 (14.9)
Rate (95% CI) 1.3 (1.3–1.3) 2.3 (2.1–2.4) 1.8 (1.7–1.9) 1.3 (1.2–1.4) 1.4 (1.4–1.5) 1.6 (1.5–1.7)  —
Rate ratio (95% CI) 1 [Ref] 1.73 (1.63–1.83) 1.39 (1.30–1.48) 1.01 (0.92–1.11) 1 [Ref] 1.12 (1.05–1.19)  —
Unknown
No. (%) 1,965 (5.4) 619 (6.6) 649 (6.5) 373 (9.6) 3,033 (6.0) 573 (6.2) 3,606 (6.1)
Rate (95% CI) 0.5 (0.5–0.5) 0.9 (0.8–0.9) 0.9 (0.8–1.0) 1.0 (0.9–1.1) 0.6 (0.6–0.6) 0.7 (0.6–0.7)  —
Rate ratio (95% CI) 1 [Ref] 1.75 (1.60–1.92) 1.83 (1.66–2.00) 2.04 (1.82–2.28) 1 [Ref] 1.13 (1.02–1.24)  —
Abbreviations: — , not applicable; CDC, Centers for Disease Control and Prevention; CI, confidence interval; NH, non-Hispanic; RUCC, rural–urban continuum codes;
USDA, US Department of Agriculture.
a Rates are per 100,000 women and are age-adjusted to the 2000 US standard population (19 age groups, Census P25–1130).
b Data are from population-based registries that participate in CDC’s National Program of Cancer Registries and/or the National Cancer Institute’s Surveillance, Epi-
demiology, and End Results Program and meet high-quality data criteria. Data from Nevada did not meet criteria in 2011, and Kansas and Minnesota do not re-
port county-level data, so were excluded. The remaining registries cover approximately 96.5% of the US population.
c Urban defined as USDA RUCC 1–3 (metropolitan counties with population sizes ≥1 million; 250,000– <1,000,000; and <250,000). Rural defined as RUCC 4–9
(nonmetropolitan counties with population sizes ≥20,000; 2,500–19,999; and <2,500).
d NH other includes non-Hispanic American Indian/Alaska Native, Asian/Pacific Islander, unspecified race, and other race and unknown.
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NH White NH Black Hispanic NH Otherd
Urban Rural Urban Rural Urban Rural Urban Rural
Localized
Rate (95% CI) 4.6 (4.5–4.7) 5.2 (5.0–5.4) 4.7 (4.6–4.9) 5.0 (4.5–5.6) 5.6 (5.4–5.8) 5.2 (4.6–5.9) 4.4 (4.2–4.6) 6.4 (5.4–7.5)
Rate ratio (95% CI) 1.13 (1.08–1.18) 1.05 (0.93–1.19) 0.93 (0.81–1.06) 1.46 (1.23–1.73)
Regional
Rate (95% CI) 3.1 (3.0–3.1) 3.9 (3.7–4.0) 5.1 (4.9–5.3) 6.2 (5.6–6.8) 5.1 (4.9–5.3) 4.6 (4.0–5.3) 3.7 (3.5–3.9) 4.7 (3.9–5.6)
Rate ratio (95% CI) 1.26 (1.21–1.32) 1.21 (1.09–1.34) 0.91 (0.78–1.05) 1.27 (1.04–1.54)
Distant
Rate (95% CI) 1.3 (1.2–1.3) 1.5 (1.4–1.6) 2.2 (2.1–2.4) 2.5 (2.1–2.9) 1.8 (1.7–1.9) 2.0 (1.5–2.4) 1.0 (0.9–1.1) 1.5 (1.0–2.1)
Rate ratio (95% CI) 1.21 (1.13–1.30) 1.11 (0.94–1.31) 1.08 (0.85–1.37) 1.40 (1.00–1.91)
Unknown
Rate (95% CI) 0.5 (0.5–0.5) 0.6 (0.5–0.7) 0.8 (0.8–0.9) 1.2 (0.9–1.5) 0.9 (0.8–1.0) 1.2 (0.9–1.7) 1.0 (0.9–1.1) 1.5 (1.0–2.1)
Rate ratio (95% CI) 1.23 (1.08–1.37) 1.38 (1.08–1.76) 1.40 (1.02–1.88) 1.52 (1.04–2.15)
Abbreviations: — , not applicable; CDC, Centers for Disease Control and Prevention; CI, confidence interval; NH, non-Hispanic; RUCC, rural–urban continuum codes;
USDA, US Department of Agriculture.
a Rates are per 100,000 women and are age-adjusted to the 2000 US standard population (19 age groups – Census P25–1130).
b Urban defined as USDA RUCC 1–3 (metropolitan counties with population sizes ≥1,000,000; 250,000–<1,000,000; and <250,000). Rural defined as RUCC 4–9
(nonmetropolitan counties with population sizes ≥20,000; 2,500–19,999; and <2,500).
c Data are from population-based registries that participate in CDC’s National Program of Cancer Registries and/or the National Cancer Institute’s Surveillance, Epi-
demiology, and End Results Program and meet high-quality data criteria. Data from Nevada did not meet criteria in 2011, and Kansas and Minnesota do not re-
port county-level data, so were excluded. The remaining registries cover approximately 96.5% of the US population.
d NH other includes non-Hispanic American Indian/Alaska Native, Asian/Pacific Islander, unspecified race, and other race and unknown.
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